amikacin has been researched along with Infections, Proteus in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (65.00) | 18.7374 |
1990's | 3 (15.00) | 18.2507 |
2000's | 1 (5.00) | 29.6817 |
2010's | 2 (10.00) | 24.3611 |
2020's | 1 (5.00) | 2.80 |
Authors | Studies |
---|---|
Guo, Q; Hooper, DC; Wang, M; Wang, X; Wu, S; Xu, X; Ye, X | 1 |
Dobashi, M; Ikeda, M; Ishii, J; Koguchi, D; Murakami, Y | 1 |
Hung, YP; Ko, WC; Lee, JC; Li, CW; Li, MC; Lin, HJ; Liu, HC; Wu, YH | 1 |
Amicosante, G; Falcone, M; Mancini, C; Mezzatesta, ML; Perilli, M; Stefani, S; Venditti, M | 1 |
Lietman, PS; Moore, RD; Smith, CR | 1 |
Jimenez, EM; Lindquist, LB; Montgomerie, JZ; Morrow, JW; Sapico, FL | 1 |
Bis, W; Jeljaszewicz, J; Kazanowski, A; Kuzniewski, P; Molska, J; Włodarczak, K | 1 |
Esparza-Ahumada, S; Morfin-Otero, R; Rodriguez-Noriega, E | 1 |
Blackshear, P; Branch, S; Chernoff, N; Hall, L | 1 |
Greenman, RL; Hoffman, TA; Sklaver, AR | 1 |
Arroyo, JC; Liebhaber, H; Sonnenwirth, AC | 1 |
Hofstetter, A; Staehler, G | 1 |
Hasegawa, Y; Kobayashi, Y; Morishita, T; Tamatani, S; Tomioka, H | 1 |
Doughty, SC; Greenberg, SB; Martin, RR | 1 |
Kobayashi, Y; Shigeta, Y; Tomioka, H | 1 |
Eickhoff, TC; Iannini, PB; LaForce, FM | 1 |
Lüthy, R | 1 |
Zhang, YP | 1 |
Garau, J; Javaloyas, M; Sanchez, C; Valverde, J | 1 |
Martin, RR; Saenz, CA; Sharp, PM | 1 |
1 review(s) available for amikacin and Infections, Proteus
Article | Year |
---|---|
[Aminoglycoside antibiotics from clinical viewpoint].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Combinations; Enterobacteriaceae Infections; Escherichia coli Infections; Gentamicins; Glomerular Filtration Rate; Kanamycin; Klebsiella Infections; Proteus Infections; Providencia; Pseudomonas Infections; Serratia; Sisomicin; Streptomycin; Tobramycin | 1975 |
3 trial(s) available for amikacin and Infections, Proteus
Article | Year |
---|---|
Short-course aminoglycoside therapy in patients with spinal cord injury. Standard dose versus low dose.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Humans; Injections, Intramuscular; Kanamycin; Proteus Infections; Providencia; Pseudomonas Infections; Random Allocation; Recurrence; Spinal Cord Injuries; Tobramycin; Urinary Bladder, Neurogenic; Urinary Tract Infections | 1980 |
Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of skin and skin structure infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Drug Administration Schedule; Escherichia coli Infections; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Proteus Infections; Proteus mirabilis; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus | 1995 |
[Amikacin in urinary tract infections with so-called problem pathogens].
Topics: Amikacin; Clinical Trials as Topic; Drug Evaluation; Escherichia coli Infections; Humans; Kanamycin; Proteus Infections; Pseudomonas Infections; Urinary Tract Infections | 1976 |
16 other study(ies) available for amikacin and Infections, Proteus
Article | Year |
---|---|
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Proteins; Base Sequence; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Proteus Infections; Proteus mirabilis; Quinolones; Sequence Analysis, DNA | 2009 |
Cefaclor as a first-line treatment for acute uncomplicated cystitis: a retrospective single-center study.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Cefaclor; Cefazolin; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Fosfomycin; Humans; Klebsiella Infections; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Proteus Infections; Retrospective Studies; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult | 2020 |
Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Blood; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Nursing Homes; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus Infections; Proteus mirabilis; Retrospective Studies; Sputum; Taiwan; Thienamycins; Urine | 2016 |
Prolonged bacteraemia caused by VIM-1 metallo-beta-lactamase-producing Proteus mirabilis: first report from Italy.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Chromosomes, Bacterial; DNA, Bacterial; Humans; Integrons; Italy; Male; Meropenem; Plasmids; Proteus Infections; Proteus mirabilis; Surgical Wound Infection; Thienamycins; Treatment Failure; Treatment Outcome | 2010 |
The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.
Topics: Adult; Aged; Amikacin; Body Temperature; Gentamicins; Gram-Negative Bacteria; Humans; Kanamycin; Kidney Diseases; Leukocyte Count; Middle Aged; Proteus Infections; Sepsis; Statistics as Topic; Tobramycin | 1984 |
Experimental infection in rabbits evoked by Pseudomonas aeruginosa, Proteus mirabilis, Escherichia coli and Klebsiella pneumoniae treated with gentamicin, amikacin and sisomicin.
Topics: Amikacin; Animals; Enterobacteriaceae Infections; Escherichia coli Infections; Gentamicins; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Proteus Infections; Proteus mirabilis; Pseudomonas Infections; Rabbits; Sisomicin | 1980 |
Infectious dermatitis in a ball python (Python regius) colony.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Boidae; Cefotaxime; Cephalosporins; Dermatitis; Disease Outbreaks; Fatal Outcome; Female; Male; Proteus Infections; Proteus vulgaris; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Infectious | 1998 |
Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli.
Topics: Adolescent; Adult; Aged; Amikacin; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Kanamycin; Klebsiella Infections; Meningitis; Proteus Infections; Sepsis; Serratia marcescens | 1978 |
Proteus rettgeri infections: a review.
Topics: Adolescent; Amikacin; Gentamicins; Humans; Male; Penicillin Resistance; Penicillins; Proteus Infections; Quadriplegia; Sepsis | 1977 |
[Amikacin treatment of septicemia due to gentamicin-resistant gram-negative bacilli (author's transl)].
Topics: Aged; Amikacin; Aorta, Thoracic; Aortic Aneurysm; Cephaloridine; Drug Resistance, Microbial; Gentamicins; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Parkinson Disease; Proteus Infections; Proteus mirabilis; Pseudomonas aeruginosa; Pseudomonas Infections; Subarachnoid Hemorrhage | 1975 |
Treatment of hospita-acquired infections with amikacin.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Cross Infection; Female; Humans; Kanamycin; Male; Middle Aged; Proteus; Proteus Infections; Urinary Tract Infections | 1977 |
[Therapeutic experience of Proteus morganii septicemia with amikacin (author's transl)].
Topics: Amikacin; Humans; Intracranial Aneurysm; Kanamycin; Male; Middle Aged; Proteus Infections; Sepsis | 1977 |
Multidrug-resistant Proteus rettgeri: an emerging problem.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Cephalothin; Cross Infection; Gentamicins; Humans; Kanamycin; Penicillin Resistance; Proteus; Proteus Infections; R Factors; Urinary Tract Infections | 1976 |
[Common pathogens in burn infection and changes in their drug sensitivity].
Topics: Amikacin; Burns; Ciprofloxacin; Female; Humans; Male; Microbial Sensitivity Tests; Piperacillin; Proteus; Proteus Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus | 1991 |
Bilateral and symmetrical osteomyelitis due to gram-negative bacilli. A report on two cases.
Topics: Adult; Amikacin; Ampicillin; Female; Gram-Negative Bacteria; Humans; Middle Aged; Osteomyelitis; Proteus Infections; Proteus mirabilis; Pseudomonas aeruginosa; Pseudomonas Infections; Urinary Tract Infections | 1985 |
Amikacin (BB-K8) treatment of multiple-drug resistant Proteus infections.
Topics: Adult; Aged; Amikacin; Drug Resistance, Microbial; Female; Humans; Kanamycin; Male; Middle Aged; Proteus Infections | 1974 |